AMAG PHARMACEUTICALS INC's ticker is AMAG and the CUSIP is 00163U106. A total of 1 filers reported holding AMAG PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $118,966 | +22.9% | 12,656 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $96,818 | +23.8% | 12,656 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $78,214 | -49.2% | 12,656 | 0.0% | 0.00% | -33.3% |
| Q4 2019 | $154,024 | +5.4% | 12,656 | 0.0% | 0.00% | +50.0% |
| Q3 2019 | $146,177 | +15.6% | 12,656 | 0.0% | 0.00% | 0.0% |
| Q2 2019 | $126,433 | -22.4% | 12,656 | 0.0% | 0.00% | -33.3% |
| Q1 2019 | $163,009 | -15.2% | 12,656 | 0.0% | 0.00% | -25.0% |
| Q4 2018 | $192,245 | -24.0% | 12,656 | 0.0% | 0.00% | -20.0% |
| Q3 2018 | $253,120 | -99.9% | 12,656 | 0.0% | 0.01% | +25.0% |
| Q2 2018 | $246,792,000 | -3.2% | 12,656 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $255,018,000 | +151696.4% | 12,656 | 0.0% | 0.00% | +100.0% |
| Q4 2017 | $168,000 | -62.2% | 12,656 | -47.6% | 0.00% | -33.3% |
| Q3 2017 | $445,000 | +0.2% | 24,140 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $444,000 | -18.4% | 24,140 | 0.0% | 0.00% | -25.0% |
| Q1 2017 | $544,000 | -35.2% | 24,140 | 0.0% | 0.00% | -33.3% |
| Q4 2016 | $840,000 | +41.9% | 24,140 | 0.0% | 0.01% | +50.0% |
| Q3 2016 | $592,000 | +2.6% | 24,140 | 0.0% | 0.00% | 0.0% |
| Q2 2016 | $577,000 | +2.1% | 24,140 | 0.0% | 0.00% | 0.0% |
| Q1 2016 | $565,000 | -22.5% | 24,140 | 0.0% | 0.00% | -33.3% |
| Q4 2015 | $729,000 | -24.0% | 24,140 | 0.0% | 0.01% | -14.3% |
| Q3 2015 | $959,000 | -34.9% | 24,140 | +13.2% | 0.01% | -30.0% |
| Q2 2015 | $1,473,000 | +33.4% | 21,324 | +5.6% | 0.01% | +25.0% |
| Q1 2015 | $1,104,000 | +43.0% | 20,198 | +11.6% | 0.01% | +60.0% |
| Q4 2014 | $772,000 | +38.8% | 18,104 | +3.9% | 0.01% | +25.0% |
| Q3 2014 | $556,000 | +39.0% | 17,421 | -9.8% | 0.00% | +33.3% |
| Q2 2014 | $400,000 | +8.4% | 19,317 | +1.4% | 0.00% | 0.0% |
| Q1 2014 | $369,000 | -22.2% | 19,057 | -2.5% | 0.00% | 0.0% |
| Q4 2013 | $474,000 | +15.0% | 19,541 | +1.9% | 0.00% | 0.0% |
| Q3 2013 | $412,000 | -3.5% | 19,180 | 0.0% | 0.00% | 0.0% |
| Q2 2013 | $427,000 | – | 19,180 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARMISTICE CAPITAL, LLC | 4,060,000 | $46,893,000 | 3.11% |
| Camber Capital Management LP | 4,390,000 | $50,705,000 | 2.67% |
| Palo Alto Investors LP | 3,078,874 | $35,561,000 | 2.37% |
| Permanens Capital L.P. | 407,811 | $4,710,000 | 1.32% |
| Fondren Management LP | 35,000 | $404,000 | 0.34% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 33,524 | $387,000 | 0.29% |
| BOOTHBAY FUND MANAGEMENT, LLC | 240,000 | $2,772,000 | 0.25% |
| Broadfin Capital, LLC | 100,000 | $1,155,000 | 0.21% |
| FOX RUN MANAGEMENT, L.L.C. | 13,687 | $158,000 | 0.14% |
| Spark Investment Management LLC | 92,200 | $1,064,000 | 0.14% |